Table 8.
Diet duration, Glucose ketone index, clinical outcomes
| Patient | Tumor type | Weeks on trial, weeks total on diet | Glucose/Ketone index | Outcome |
|---|---|---|---|---|
| 1 | Cholangiocarcinoma | Less than 2 weeks | NA | Dropped out of study. Menu planning difficulties. |
| 2 | Glioblastoma | 4 | NA | Progressive disease at 4 weeks. |
| 3 | Prostate cancer | 4 | 14.30 | Stable tumor size at 4 weeks, but PSA was rising; dropped out of study |
| 4 | Melanoma | 16 on trial, continued diet post trial till 80 weeks | 17 (week 4) 23 (week 8) 14 (week 16) |
Stable disease at 16 weeks, mixed findings, slow progression, active until shortly before death at 80 weeks |
| 5 | Renal cell cancer | 4 | 3.23 | Progressive disease |
| 6 | Pancreas | 4 | 2.06 | Progressive disease at 4 weeks. Muscular body builder habitus. Worked out daily. |
| 7 | Colon cancer | 8 | 8.6 (week 4) 4.3 (week 8) |
Stable at 4 weeks, mixed mixed CT scan findings and rising CEA at 8 weeks. |
| 8 | Papillary thyroid | 8 | 1.9 (week 4) 5.2 (week 8) |
Stable at 8 weeks, but removed because of grade 3 weight loss; still alive 15 months later. Declined follow up bloodwork. |
| 9 | Melanoma | 16 weeks on trial, continued diet post trial till 116 weeks | 7.8 (week 4) 28 (week 8) 31 (week 16) |
Stable disease at 16 weeks, and at 92 weeks. Active till 2 days prior to death at 116 weeks. |
| 10 | Parotid | 4 | 18.3 | Progressed at 4 weeks. Diabetic. |
| 11 | Astrocytoma | NA | NA | Disqualified due to negative PET scan |
| 12 | Melanoma | 16, continued diet post trial till 100 weeks. He reported at this time that he stopped the diet at around 80 weeks. | 4.5 (week 4) 12 (week 8) 80 (week 16) |
Stable at 16 weeks. Underwent metastectomy of remaining axillary disease. PET/CT scan no evidence of disease at 131 weeks. |
| 13 | Head and neck | <4 | 12.14 | Achieved ketosis in only 2 weeks out of 4. Progressed at 4 weeks. |
| 14 | Hepatoma | NA | NA | Progressed before starting diet. |
| 15 | Pancreas- post lung transplant; on multiple immunosuppresive anti-rejection drugs. | NA | NA | Very rapidly progressive disease. Progressed before starting diet. |
| 16 | Lung cancer | NA | NA | Had acute cardiac event and changed his mind before starting the trial. |
| 17 | Lung cancer | 16 | 6.1 (week 4) 5.2 (week 8) 3.2 (week 16) |
Stable at 4,8 and 16 weeks. Dieted for a week after 16, then back to standard diet. Died at 40 weeks. |